Daniel Davis - Penumbra President of North America
| PEN Stock | USD 203.00 0.28 0.14% |
President
Mr. Daniel Donen Davis serves as Chief Commercial Officer of the Company. Mr. Davis joined Penumbra in 2007. He has served as President, North America, since 2015 and Chief Commercial Officer since 2017. Mr. Davis previously served as Vice President of Strategy from 2013 to 2014 and as Director of Marketing from 2011 to 2012. Mr. Davis joined our sales team in 2007, serving as a Sales Trainer from 2008 to 2011. Before joining Penumbra, Mr. Davis held various sales and marketing positions at Boston Scientific Corporation since 2019.
| Age | 39 |
| Tenure | 5 years |
| Address | One Penumbra Place, Alameda, CA, United States, 94502 |
| Phone | 510 748 3200 |
| Web | https://www.penumbrainc.com |
Penumbra Management Efficiency
The company has Return on Asset of 0.0392 % which means that on every $100 spent on assets, it made $0.0392 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0835 %, implying that it generated $0.0835 on every 100 dollars invested. Penumbra's management efficiency ratios could be used to measure how well Penumbra manages its routine affairs as well as how well it operates its assets and liabilities. As of the 23rd of April 2024, Return On Tangible Assets is likely to grow to 0.07. Also, Return On Capital Employed is likely to grow to 0.06. At this time, Penumbra's Asset Turnover is very stable compared to the past year.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Kevin Karas | National Research Corp | 60 | |
| Jeffery Doster | HealthStream | 51 | |
| Larry Trittschuh | HealthEquity | 52 | |
| Thomas Schultz | HealthStream | 49 | |
| Frode Jensen | HealthEquity | 64 | |
| Edward Pearson | HealthStream | 61 | |
| Scott McQuigg | HealthStream | 50 | |
| Gary Robinson | HealthEquity | 55 | |
| Steven Jackson | National Research Corp | 42 | |
| Trisha Coady | HealthStream | 48 | |
| Edward Bloomberg | HealthEquity | 41 | |
| William Otten | HealthEquity | 52 | |
| Jeffrey Cunningham | HealthStream | 57 | |
| Michael Sousa | HealthStream | 55 | |
| Michael Collier | HealthStream | 48 | |
| Jonathan Maack | Definitive Healthcare Corp | 45 | |
| Jonathan Soldan | HealthEquity | 32 | |
| Angelique Hill | HealthEquity | 55 | |
| Ashley Dreier | HealthEquity | 44 | |
| Delano Ladd | HealthEquity | 43 | |
| Mollie Condra | HealthStream | N/A | |
Management Performance
| Return On Equity | 0.0835 | ||||
| Return On Asset | 0.0392 |
Penumbra Leadership Team
Elected by the shareholders, the Penumbra's board of directors comprises two types of representatives: Penumbra inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Penumbra. The board's role is to monitor Penumbra's management team and ensure that shareholders' interests are well served. Penumbra's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Penumbra's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ben Tompkins, Executive Development | ||
| Surbhi Sarna, Independent Director | ||
| Bridget ORourke, Independent Director | ||
| Adam Elsesser, Chairman of the Board, Chief Executive Officer | ||
| James Pray, President International | ||
| Robert Evans, Executive Vice President General Counsel, Secretary | ||
| Shruthi Narayan, Executive Interventional | ||
| Gita Barry, President Healthcare | ||
| Kevin Sullivan, Independent Director | ||
| Lynn Rothman, Executive Vice President, Chief Business Officer | ||
| Arani MD, CoFounder Director | ||
| Sridhar Kosaraju, President, Chief Financial Officer | ||
| Pankaj Tiwari, Executive Officer | ||
| Harpreet Grewal, Independent Director | ||
| Maggie Yuen, Chief Financial Officer | ||
| Jee HamlynHarris, Investor Officer | ||
| Don Kassing, Presiding Independent Director | ||
| Kevin Sullivanhas, Independent Director | ||
| Ben Sorci, Executive Operations | ||
| Lambert Shiu, Chief Accounting Officer | ||
| Johanna Roberts, Executive Vice President General Counsel, Secretary | ||
| Daniel Davis, President of North America | ||
| Jason Mills, Executive Strategy | ||
| Thomas Wilder, Independent Director | ||
| Walter Wang, Director | ||
| Arani Bose, Executive Director and Chief Innovator | ||
| Janet Leeds, Lead Independent Director |
Penumbra Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Penumbra a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0835 | ||||
| Return On Asset | 0.0392 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.12 % | ||||
| Current Valuation | 7.79 B | ||||
| Shares Outstanding | 38.7 M | ||||
| Shares Owned By Insiders | 3.81 % | ||||
| Shares Owned By Institutions | 89.87 % | ||||
| Number Of Shares Shorted | 1.93 M | ||||
| Price To Earning | 191.13 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Penumbra in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Penumbra's short interest history, or implied volatility extrapolated from Penumbra options trading.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Penumbra using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Penumbra. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. To learn how to invest in Penumbra Stock, please use our How to Invest in Penumbra guide.Note that the Penumbra information on this page should be used as a complementary analysis to other Penumbra's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Complementary Tools for Penumbra Stock analysis
When running Penumbra's price analysis, check to measure Penumbra's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Penumbra is operating at the current time. Most of Penumbra's value examination focuses on studying past and present price action to predict the probability of Penumbra's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Penumbra's price. Additionally, you may evaluate how the addition of Penumbra to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
Is Penumbra's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Penumbra. If investors know Penumbra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Penumbra listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 12.519 | Earnings Share 2.31 | Revenue Per Share 27.565 | Quarterly Revenue Growth 0.287 | Return On Assets 0.0392 |
The market value of Penumbra is measured differently than its book value, which is the value of Penumbra that is recorded on the company's balance sheet. Investors also form their own opinion of Penumbra's value that differs from its market value or its book value, called intrinsic value, which is Penumbra's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Penumbra's market value can be influenced by many factors that don't directly affect Penumbra's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Penumbra's value and its price as these two are different measures arrived at by different means. Investors typically determine if Penumbra is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Penumbra's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.